H
Heval M. Kelli
Researcher at Emory University
Publications - 56
Citations - 2021
Heval M. Kelli is an academic researcher from Emory University. The author has contributed to research in topics: Coronary artery disease & Heart failure. The author has an hindex of 19, co-authored 54 publications receiving 1238 citations. Previous affiliations of Heval M. Kelli include Cardiovascular Institute of the South & Morehouse School of Medicine.
Papers
More filters
Journal ArticleDOI
Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.
William M. Schultz,Heval M. Kelli,John Lisko,Tina Varghese,Jia Shen,Pratik B. Sandesara,Arshed A. Quyyumi,Herman A. Taylor,Martha Gulati,John Gordon Harold,Jennifer H. Mieres,Keith C. Ferdinand,George A. Mensah,Laurence S. Sperling +13 more
TL;DR: The current state of knowledge on the impact of SES on the incidence, treatment, and outcomes of CVD in high-income societies is reviewed and future research directions aimed at the elimination of these adverse factors, and the integration of measures of S ES into the customization of cardiovascular treatment are suggested.
Journal ArticleDOI
The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review
Yousuf K Gandapur,Sina Kianoush,Heval M. Kelli,Satish Misra,Bruno Urrea,Michael J. Blaha,Garth Graham,Francoise A Marvel,Seth S. Martin +8 more
TL;DR: Current evidence suggests that mHealth tools can improve medication adherence in patients with cardiovascular diseases, however, high-quality clinical trials of sufficient size and duration are needed to move the field forward and justify use in routine care.
Journal ArticleDOI
The Wild Wild West: A Framework to Integrate mHealth Software Applications and Wearables to Support Physical Activity Assessment, Counseling and Interventions for Cardiovascular Disease Risk Reduction
Felipe Lobelo,Heval M. Kelli,Sheri Chernetsky Tejedor,Michael Pratt,Michael V. McConnell,Seth S. Martin,Gregory J. Welk +6 more
TL;DR: The validity, utility and feasibility of implementing mHealth technology in clinical settings are reviewed and an organizational framework to support PA assessment, counseling and referrals to community resources for CVD risk reduction interventions is proposed.
Journal ArticleDOI
The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction
Pratik B. Sandesara,Wesley T. O'Neal,Heval M. Kelli,Ayman Samman-Tahhan,Muhammad Hammadah,Arshed A. Quyyumi,Laurence S. Sperling +6 more
TL;DR: Diabetes is associated with adverse cardiovascular outcomes in HFpEF, and the inherent risk of adverse outcomes inHFpEF patients with diabetes varies by the presence of microvascular complications.
Journal ArticleDOI
Ten things to know about ten cardiovascular disease risk factors
Harold E. Bays,Pam R. Taub,Elizabeth Epstein,Erin D. Michos,Richard A. Ferraro,Alison L. Bailey,Heval M. Kelli,Keith C. Ferdinand,Melvin R. Echols,Howard Weintraub,John Bostrom,Heather M. Johnson,Kara K. Hoppe,Michael D. Shapiro,Charles A German,Salim S. Virani,Aliza Hussain,Christie M. Ballantyne,Ali M. Agha,Peter P. Toth +19 more
TL;DR: The intent of the “ASPC Top Ten CVD Risk Factors 2021 Update” is to provide a succinct overview of things to know about ten common CVD risk factors applicable to preventive cardiology.